Cooking classes and coaching aim to boost kidney health in black communities
NCT ID NCT07175896
First seen Jun 26, 2026 · Last updated Aug 28, 2026 · Updated 2 times
Summary
This study tests whether a 16-week program of group diet coaching and hands-on cooking classes can help Black Americans at risk for chronic kidney disease stick to the low-sodium DASH diet. The program involves 48 participants who either get the coaching and classes right away or after a delay. The goal is to see if the program is practical and well-liked, not yet to prove it prevents kidney disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- low-sodium DASH diet coaching and cooking classes
- What this could lead to
- If successful, this program could offer a practical way to help Black Americans adopt a kidney-friendly diet and lower their risk of chronic kidney disease.
- What could go wrong
- This is a small, early feasibility study with only 48 participants, so results may not apply broadly. The program's long-term impact on kidney health is not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 48 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * self-identified Black race * mild to moderate chronic kidney disease, CKD (eGFR ≥ 60 ml/min/1.73m2 plus albuminuria \[Stages 1 or 2\] or eGFR 45-59 ml/min/1.73m2 \[Stage 3a\]) or normal kidney function with at least 1 of the following CKD risk factors: * Type 2 diabetes or pre-diabetes * hypertension * cardiovascular disease (CVD) * obesity * age 60 or older Exclusion Criteria: * eGFR \<45 ml/min/1.73m2 (i.e., CKD stages 3b, 4, 5) * urine dipstick consistent with nephrotic range proteinuria (\>3 g) * receiving dialysis or history of kidney transplant * Type 1 diabetes * pregnant, lactating or planning to become pregnant in next 6 months * lack of internet access and videoconferencing capabilities * planning to relocate in the next 9 months * unable to read, write and speak in English * participating in another research study involving diet, exercise or weight loss
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Clinical Research
Durham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Two drugs, one goal: can finerenone or semaglutide cut kidney damage markers?
- One team, three conditions: can coordinated care tame heart, kidney, and diabetes?